Frost & Sullivan releases the 'Independent Market Study on the Third-Party R&D and Manufacturing Industry of In Vitro Diagnostic Instruments and Consumables'

Frost & Sullivan hereby releases the 'Independent Market Research Report on the Third-Party R&D and Manufacturing Industry of In Vitro Diagnostic Instruments and Consumables'. The CDMO of in vitro diagnostic instruments and consumables occupies a midstream position in the in vitro diagnostic industry chain, purchasing the relevant raw materials required for the production and R&D of in vitro diagnostic instruments and consumables from upstream material and accessory suppliers. Under the medical device registrant system, entities such as research institutions, universities, hospitals, and researchers are allowed to develop products through commissioning and carry out post-market production, becoming new entities in the medical device R&D outsourcing service industry, leading to increased demand for services such as R&D and clinical trials. This integrated and more customized third-party R&D and manufacturing model, while meeting the needs of commissioning parties, reduces the pressure on in vitro diagnostic enterprises and makes the industrial chain division of labor clearer.